
GeneDx Investors Face Deadline in Securities Fraud Class Action
A 49% collapse in GeneDx Holdings stock has triggered a class action lawsuit, with investors now facing an August 3, 2026, deadline to seek lead plaintiff status. The litigation follows allegations that the company misled shareholders regarding the financial performance of its acquisition of Fabric Genomics.
























